0 XP   0   0   0

Elixinol Global Ltd
Buy, Hold or Sell?

I guess you are interested in Elixinol Global Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Elixinol Global Ltd

Let's start. I'm going to help you getting a better view of Elixinol Global Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Elixinol Global Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Elixinol Global Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Elixinol Global Ltd. The closing price on 2022-10-03 was A$0.025 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Elixinol Global Ltd Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Elixinol Global Ltd.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Elixinol Global Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Elixinol Global Ltd to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -33.9% means that $-0.34 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Elixinol Global Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-33.9%+33.9%
TTM-33.9%YOY-135.8%+101.9%
TTM-33.9%5Y-177.1%+143.2%
5Y-177.1%10Y-177.1%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.7%-0.7%
TTM-33.9%1.0%-34.9%
YOY-135.8%1.7%-137.5%
5Y-177.1%0.6%-177.7%
10Y-177.1%1.2%-178.3%
1.1.2. Return on Assets

Shows how efficient Elixinol Global Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Elixinol Global Ltd to the Drug Manufacturers-Specialty & Generic industry mean.
  • -6.1% Return on Assets means that Elixinol Global Ltd generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Elixinol Global Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-6.1%+6.1%
TTM-6.1%YOY-22.1%+16.0%
TTM-6.1%5Y-21.5%+15.4%
5Y-21.5%10Y-21.5%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2%-0.2%
TTM-6.1%0.2%-6.3%
YOY-22.1%0.1%-22.2%
5Y-21.5%-0.1%-21.4%
10Y-21.5%0.2%-21.7%
1.1.3. Return on Equity

Shows how efficient Elixinol Global Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Elixinol Global Ltd to the Drug Manufacturers-Specialty & Generic industry mean.
  • 0.0% Return on Equity means the company generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Elixinol Global Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-8.1%+8.1%
TTM-8.1%YOY-26.8%+18.7%
TTM-8.1%5Y-26.1%+18.0%
5Y-26.1%10Y-26.1%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.8%-0.8%
TTM-8.1%0.6%-8.7%
YOY-26.8%0.6%-27.4%
5Y-26.1%0.1%-26.2%
10Y-26.1%0.5%-26.6%

1.2. Operating Efficiency of Elixinol Global Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Elixinol Global Ltd is operating .

  • Measures how much profit Elixinol Global Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Elixinol Global Ltd to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Elixinol Global Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-18.7%+18.7%
TTM-18.7%YOY-37.4%+18.7%
TTM-18.7%5Y-70.3%+51.6%
5Y-70.3%10Y-70.3%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%-3.5%
TTM-18.7%2.3%-21.0%
YOY-37.4%3.9%-41.3%
5Y-70.3%3.5%-73.8%
10Y-70.3%1.9%-72.2%
1.2.2. Operating Ratio

Measures how efficient Elixinol Global Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are $0.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Elixinol Global Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.118-0.118
TTM0.118YOY0.238-0.120
TTM0.1185Y0.378-0.260
5Y0.37810Y0.3780.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.480-1.480
TTM0.1181.435-1.317
YOY0.2381.383-1.145
5Y0.3781.363-0.985
10Y0.3781.160-0.782

1.3. Liquidity of Elixinol Global Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Elixinol Global Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 358.2% means the company has $3.58 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Elixinol Global Ltd:

  • The MRQ is 3.582. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.868. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.582TTM3.868-0.286
TTM3.868YOY6.390-2.522
TTM3.8685Y6.131-2.263
5Y6.13110Y6.1310.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5821.887+1.695
TTM3.8681.900+1.968
YOY6.3902.104+4.286
5Y6.1312.156+3.975
10Y6.1311.840+4.291
1.3.2. Quick Ratio

Measures if Elixinol Global Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 85.7% means the company can pay off $0.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Elixinol Global Ltd:

  • The MRQ is 0.857. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.443. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ0.857TTM1.443-0.586
TTM1.443YOY2.895-1.452
TTM1.4435Y2.305-0.863
5Y2.30510Y2.3050.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8570.641+0.216
TTM1.4430.784+0.659
YOY2.8950.809+2.086
5Y2.3050.838+1.467
10Y2.3050.834+1.471

1.4. Solvency of Elixinol Global Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Elixinol Global Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.25 means that Elixinol Global Ltd assets are financed with 24.7% credit (debt) and the remaining percentage (100% - 24.7%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Elixinol Global Ltd:

  • The MRQ is 0.247. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.234. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.247TTM0.234+0.013
TTM0.234YOY0.182+0.051
TTM0.2345Y0.164+0.070
5Y0.16410Y0.1640.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2470.429-0.182
TTM0.2340.412-0.178
YOY0.1820.391-0.209
5Y0.1640.390-0.226
10Y0.1640.396-0.232
1.4.2. Debt to Equity Ratio

Measures if Elixinol Global Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 32.8% means that company has $0.33 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Elixinol Global Ltd:

  • The MRQ is 0.328. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.306. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.328TTM0.306+0.022
TTM0.306YOY0.224+0.082
TTM0.3065Y0.244+0.062
5Y0.24410Y0.2440.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3280.688-0.360
TTM0.3060.677-0.371
YOY0.2240.624-0.400
5Y0.2440.678-0.434
10Y0.2440.689-0.445

2. Market Valuation of Elixinol Global Ltd

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Elixinol Global Ltd.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -0.48 means the investor is paying $-0.48 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Elixinol Global Ltd:

  • The EOD is -0.601. Company is losing money. -2
  • The MRQ is -0.481. Company is losing money. -2
  • The TTM is -1.209. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.601MRQ-0.481-0.120
MRQ-0.481TTM-1.209+0.728
TTM-1.209YOY-0.476-0.733
TTM-1.2095Y185.145-186.354
5Y185.14510Y185.1450.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-0.6010.297-0.898
MRQ-0.4810.416-0.897
TTM-1.2091.360-2.569
YOY-0.4763.493-3.969
5Y185.1456.176+178.969
10Y185.1456.668+178.477
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Elixinol Global Ltd.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Elixinol Global Ltd:

  • The MRQ is 0.008. Very good. +2
  • The TTM is 0.014. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.008TTM0.014-0.006
TTM0.014YOY0.032-0.018
TTM0.0145Y0.0140.000
5Y0.01410Y0.0140.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0080.003+0.005
TTM0.0140.020-0.006
YOY0.0320.0320.000
5Y0.0140.026-0.012
10Y0.0140.029-0.015

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Elixinol Global Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.32 means the investor is paying $0.32 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Elixinol Global Ltd:

  • The EOD is 0.406. Very good. +2
  • The MRQ is 0.325. Very good. +2
  • The TTM is 0.985. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.406MRQ0.325+0.081
MRQ0.325TTM0.985-0.660
TTM0.985YOY1.323-0.338
TTM0.9855Y1.547-0.562
5Y1.54710Y1.5470.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.4061.424-1.018
MRQ0.3251.617-1.292
TTM0.9852.042-1.057
YOY1.3232.274-0.951
5Y1.5472.006-0.459
10Y1.5471.538+0.009

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Elixinol Global Ltd.


4. Summary

4.1. Key Performance Indicators

The key performance indicators of Elixinol Global Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.0620.064-3%0.129-52%0.634-90%0.634-90%
Book Value Per Share Growth----0.0020%-0.0370%0.003-100%0.003-100%
Current Ratio--3.5823.868-7%6.390-44%6.131-42%6.131-42%
Debt To Asset Ratio--0.2470.234+6%0.182+35%0.164+51%0.164+51%
Debt To Equity Ratio--0.3280.306+7%0.224+46%0.244+34%0.244+34%
Dividend Per Share----0%-0%-0%-0%
Eps---0.012-0.010-10%-0.026+123%-0.074+547%-0.074+547%
Eps Growth---59.541-83.345+40%-5.097-91%719.606-108%719.606-108%
Gains Per Share----0.0020%-0.0370%0.003-100%0.003-100%
Gross Profit Margin---0.250-100%0.500-100%2.016-100%2.016-100%
Net Profit Margin----0.3390%-1.3580%-1.7710%-1.7710%
Operating Margin----0.1870%-0.3740%-0.7030%-0.7030%
Operating Ratio---0.118-100%0.238-100%0.378-100%0.378-100%
Pb Ratio0.406+20%0.3250.985-67%1.323-75%1.547-79%1.547-79%
Pe Ratio-0.601-25%-0.481-1.209+151%-0.476-1%185.145-100%185.145-100%
Peg Ratio--0.0080.014-42%0.032-75%0.014-43%0.014-43%
Price Per Share0.025+20%0.0200.064-69%0.151-87%1.038-98%1.038-98%
Quick Ratio--0.8571.443-41%2.895-70%2.305-63%2.305-63%
Return On Assets----0.0610%-0.2210%-0.2150%-0.2150%
Return On Equity----0.0810%-0.2680%-0.2610%-0.2610%
 EOD+1 -2MRQTTM+5 -8YOY+6 -75Y+6 -910Y+6 -9

4.2. Fundamental Score

Let's check the fundamental score of Elixinol Global Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.601
Price to Book Ratio (EOD)Between0-10.406
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.857
Current Ratio (MRQ)Greater than13.582
Debt to Asset Ratio (MRQ)Less than10.247
Debt to Equity Ratio (MRQ)Less than10.328
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Elixinol Global Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.539
Ma 20Greater thanMa 500.032
Ma 50Greater thanMa 1000.036
Ma 100Greater thanMa 2000.036
OpenGreater thanClose0.026
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in AUD. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Assets-
Total Current Assets12,804
Long-term Assets12,804
Total Current Assets
Net Receivables 3,064
Inventory 2,224
Total Current Assets  (as reported)12,804
Total Current Assets  (calculated)5,288
+/- 7,516
Long-term Assets
Property Plant Equipment 1,404
Long-term Assets  (as reported)0
Long-term Assets  (calculated)1,404
+/- 1,404

Liabilities & Shareholders' Equity

Total Current Liabilities3,575
Long-term Liabilities-
Total Stockholder Equity-
Total Current Liabilities
Accounts payable 1,696
Other Current Liabilities 65
Total Current Liabilities  (as reported)3,575
Total Current Liabilities  (calculated)1,761
+/- 1,814
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock218,122
Retained Earnings -215,205
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)2,917
+/- 2,917
Other
Net Tangible Assets 12,316



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312006-06-302006-03-312005-12-312005-09-30
> Total Assets 
713,532
713,532
963,188
963,188
0
107,396
107,396
153,694
153,694
195,916
195,916
120,990
121,069
0
40,979
0
42,470
0
31,259
0
25,332
0
0
0025,332031,259042,470040,9790121,069120,990195,916195,916153,694153,694107,396107,3960963,188963,188713,532713,532
   > Total Current Assets 
209,059
209,059
239,815
239,815
0
21,539
21,539
56,955
56,955
78,779
78,779
51,357
51,357
28,978
28,978
35,354
35,354
24,205
24,205
19,588
19,588
12,804
12,804
12,80412,80419,58819,58824,20524,20535,35435,35428,97828,97851,35751,35778,77978,77956,95556,95521,53921,5390239,815239,815209,059209,059
       Cash And Cash Equivalents 
101,079
101,079
39,802
39,802
0
14,171
14,171
42,922
42,922
48,141
48,141
20,244
20,244
0
16,769
0
27,743
0
18,962
0
12,649
0
0
0012,649018,962027,743016,769020,24420,24448,14148,14142,92242,92214,17114,171039,80239,802101,079101,079
       Short-term Investments 
2,114
2,114
3,191
3,191
0
0
0
0
0
0
0
0
105
0
0
0
85
0
0
0
0
0
0
00000085000105000000003,1913,1912,1142,114
       Net Receivables 
43,577
43,577
56,220
56,220
0
1,949
1,949
3,443
3,366
4,141
4,141
1,624
1,536
1,254
1,254
1,700
1,191
2,010
2,010
3,511
2,970
3,064
3,064
3,0643,0642,9703,5112,0102,0101,1911,7001,2541,2541,5361,6244,1414,1413,3663,4431,9491,949056,22056,22043,57743,577
       Inventory 
52,085
52,085
108,254
108,254
0
4,030
4,030
6,976
6,976
20,043
20,043
21,314
21,314
8,891
8,891
4,735
4,735
2,035
2,035
2,201
2,201
2,224
2,224
2,2242,2242,2012,2012,0352,0354,7354,7358,8918,89121,31421,31420,04320,0436,9766,9764,0304,0300108,254108,25452,08552,085
       Other Current Assets 
10,204
10,204
32,348
32,348
0
1,389
1,389
36
3,691
6,454
6,454
1,861
8,158
2,064
2,064
283
1,600
0
1,198
170
1,768
0
0
001,7681701,19801,6002832,0642,0648,1581,8616,4546,4543,691361,3891,389032,34832,34810,20410,204
   > Long-term Assets 
0
0
0
0
0
0
0
0
96,739
0
0
0
69,712
0
0
0
7,116
0
0
0
5,744
0
0
005,7440007,11600069,71200096,73900000000
       Property Plant Equipment 
368,007
368,007
579,082
579,082
0
2,772
2,772
5,966
5,966
16,915
16,915
17,008
17,008
7,570
7,570
3,883
3,883
3,701
3,701
2,481
2,481
1,404
1,404
1,4041,4042,4812,4813,7013,7013,8833,8837,5707,57017,00817,00816,91516,9155,9665,9662,7722,7720579,082579,082368,007368,007
       Goodwill 
7,576
7,576
7,780
7,780
0
68,730
68,730
74,623
74,623
75,406
75,406
27,136
28,226
0
0
0
0
0
0
0
0
0
0
000000000028,22627,13675,40675,40674,62374,62368,73068,73007,7807,7807,5767,576
       Long Term Investments 
11,244
11,244
11,263
11,263
0
2,114
2,114
4,524
4,524
10,544
10,544
8,403
8,403
0
0
0
2,316
0
0
0
2,617
0
0
002,6170002,3160008,4038,40310,54410,5444,5244,5242,1142,114011,26311,26311,24411,244
       Intangible Assets 
65,042
65,042
0
0
0
11,839
80,569
11,626
11,626
11,475
86,881
11,768
11,768
0
1,137
0
917
0
714
0
463
0
0
004630714091701,137011,76811,76886,88111,47511,62611,62680,56911,83900065,04265,042
       Long-term Assets Other 
0
0
0
0
0
0
0
0
-724
0
0
0
69,712
0
0
0
0
0
0
0
183
0
0
00183000000069,712000-72400000000
> Total Liabilities 
440,399
440,399
570,461
570,461
0
7,828
7,828
9,959
9,959
11,689
12,343
9,687
9,687
0
8,794
0
6,819
0
6,049
0
6,255
0
0
006,25506,04906,81908,79409,6879,68712,34311,6899,9599,9597,8287,8280570,461570,461440,399440,399
   > Total Current Liabilities 
116,731
116,731
192,998
192,998
0
4,349
4,349
7,198
7,198
6,675
6,675
6,011
6,011
6,412
6,412
4,995
4,995
4,245
4,245
4,715
4,715
3,575
3,575
3,5753,5754,7154,7154,2454,2454,9954,9956,4126,4126,0116,0116,6756,6757,1987,1984,3494,3490192,998192,998116,731116,731
       Short-term Debt 
5,789
5,789
15,284
15,284
0
0
0
0
0
0
0
0
989
0
0
0
920
0
0
0
1,175
0
0
001,1750009200009890000000015,28415,2845,7895,789
       Short Long Term Debt 
5,789
5,789
15,284
15,284
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
428
0
0
00428000000000000000015,28415,2845,7895,789
       Accounts payable 
68,301
68,301
104,282
104,282
0
1,235
1,235
3,598
3,598
4,200
4,200
1,787
1,787
3,377
3,377
1,818
1,818
2,154
2,154
1,362
1,362
1,696
1,696
1,6961,6961,3621,3622,1542,1541,8181,8183,3773,3771,7871,7874,2004,2003,5983,5981,2351,2350104,282104,28268,30168,301
       Other Current Liabilities 
35,596
35,596
55,961
55,961
0
2,592
2,592
3,072
3,600
1,189
1,189
1,802
3,235
1,605
1,605
967
2,257
854
854
897
2,178
65
65
65652,1788978548542,2579671,6051,6053,2351,8021,1891,1893,6003,0722,5922,592055,96155,96135,59635,596
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
2,761
0
0
0
3,676
0
0
0
1,824
0
0
0
1,540
0
0
001,5400001,8240003,6760002,76100000000
       Long term Debt Total 
0
0
0
0
0
0
250
0
250
0
3,718
0
3,676
0
2,382
0
1,732
0
1,804
0
1,473
0
0
001,47301,80401,73202,38203,67603,71802500250000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
4,665
0
0
0
2,494
0
0
0
2,037
0
0
002,0370002,4940004,665000000000000
> Total Stockholder Equity
244,971
244,971
366,529
366,529
0
99,568
99,568
143,735
143,735
183,573
183,573
111,334
111,413
0
32,185
0
35,651
0
25,210
0
19,077
0
0
0019,077025,210035,651032,1850111,413111,334183,573183,573143,735143,73599,56899,5680366,529366,529244,971244,971
   Common Stock
179,953
179,953
283,999
283,999
0
101,800
101,800
139,612
139,612
187,240
187,240
188,771
188,771
198,566
198,566
217,730
217,730
217,620
217,620
218,058
218,058
218,122
218,122
218,122218,122218,058218,058217,620217,620217,730217,730198,566198,566188,771188,771187,240187,240139,612139,612101,800101,8000283,999283,999179,953179,953
   Retained Earnings 
70,703
70,703
89,124
89,124
0
-2,591
-2,232
-3,571
-3,571
-13,475
-3,667
-86,544
-86,544
-176,846
-176,846
-191,050
-191,050
-201,878
-201,878
-208,075
-208,075
-215,205
-215,205
-215,205-215,205-208,075-208,075-201,878-201,878-191,050-191,050-176,846-176,846-86,544-86,544-3,667-13,475-3,571-3,571-2,232-2,591089,12489,12470,70370,703
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
-5,685
-5,685
-6,594
-6,594
0
359
359
7,694
7,694
9,808
9,808
9,186
9,186
10,465
10,465
8,971
8,971
9,468
9,468
9,094
9,094
9,546
9,546
9,5469,5469,0949,0949,4689,4688,9718,97110,46510,4659,1869,1869,8089,8087,6947,6943593590-6,594-6,594-5,685-5,685



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue14,128
Cost of Revenue-6,722
Gross Profit7,4067,406
 
Operating Income (+$)
Gross Profit7,406
Operating Expense-31,648
Operating Income-24,242-24,242
 
Operating Expense (+$)
Research Development-
Selling General Administrative19,939
Selling And Marketing Expenses5,545
Operating Expense31,64825,484
 
Net Interest Income (+$)
Interest Income-8
Interest Expense-0
Net Interest Income-63-8
 
Pretax Income (+$)
Operating Income-24,242
Net Interest Income-63
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-27,973-20,511
EBIT - interestExpense = -27,973
-27,973
-27,853
Interest Expense0
Earnings Before Interest and Taxes (ebit)-27,973-27,973
Earnings Before Interest and Taxes (ebitda)-25,670
 
After tax Income (+$)
Income Before Tax-27,973
Tax Provision--65
Net Income From Continuing Ops-27,853-27,908
Net Income-27,853
Net Income Applicable To Common Shares-17,025
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses38,370
Total Other Income/Expenses Net-3,73163
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
8 hours ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
8 hours ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
8 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
8 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
8 hours ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
8 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
8 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
8 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
9 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart